Markets:

Overview

News

Currencies

International

Treasuries

Azenta, Inc. - Common Stock (NQ:AZTA)

17.02 -0.01 (-0.06%)

Streaming Delayed Price Updated: 2:43 PM EDT, May 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Azenta, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

AZTA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

May 13, 2026

From Kirby McInerney LLP

Via GlobeNewswire

Securities Fraud Investigation Into Azenta, Inc. (AZTA) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

May 13, 2026

From Glancy Prongay Wolke & Rotter

Via Business Wire

Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

May 13, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Azenta’s Q1 Earnings Call: Our Top 5 Analyst Questions

May 13, 2026

Azenta’s first quarter was marked by operational challenges and a more cautious demand environment, which contributed to results well below market expectatio...

Via StockStory

Topics Earnings

1 Russell 2000 Stock Worth Your Attention and 2 We Question

May 13, 2026

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...

Via StockStory

AZENTA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Azenta, Inc. on Behalf of Azenta Stockholders and Encourages Investors to Contact the Firm

May 12, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Securities Fraud Investigation Into Azenta, Inc. (AZTA) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

May 12, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

AZTA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

May 11, 2026

From Kirby McInerney LLP

Via GlobeNewswire

AZENTA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

May 08, 2026

From Kirby McInerney LLP

Via Business Wire

Azenta (AZTA) Q2 2026 Earnings Call Transcript ↗

May 06, 2026

Azenta (AZTA) Q2 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Azenta (AZTA) Reports Earnings Tomorrow: What To Expect

May 04, 2026

Life sciences company Azenta (NASDAQ:AZTA) will be announcing earnings results this Wednesday before market hours. Here’s what you need to know. Azenta beat ...

Via StockStory

2 Cash-Heavy Stocks on Our Buy List and 1 We Turn Down

April 23, 2026

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c...

Via StockStory

1 Healthcare Stock to Target This Week and 2 We Ignore

April 22, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-...

Via StockStory

3 Stocks Under $50 We’re Skeptical Of

April 17, 2026

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline...

Via StockStory

Curious about the stocks that are showing activity after the closing bell on Thursday? ↗

April 16, 2026

Via Chartmill

Wondering what's happening in today's after-hours session? ↗

April 01, 2026

Via Chartmill

Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Via StockStory

Topics Economy Government Stocks

Q4 Earnings Highs And Lows: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks

March 22, 2026

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind...

Via StockStory

1 Cash-Producing Stock with Exciting Potential and 2 We Ignore

March 20, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

3 Unprofitable Stocks That Concern Us

March 19, 2026

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...

Via StockStory

Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Via StockStory

Topics Economy Government World Trade

3 Reasons AZTA is Risky and 1 Stock to Buy Instead

March 02, 2026

Over the last six months, Azenta’s shares have sunk to $25.86, producing a disappointing 12% loss - a stark contrast to the S&P 500’s 6.6% gain. This was par...

Via StockStory

Topics Stocks

1 Small-Cap Stock to Research Further and 2 Facing Headwinds

February 26, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

3 Stocks Under $50 with Warning Signs

February 25, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Via StockStory

Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know

February 23, 2026

A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court...

Via StockStory

Topics Government World Trade

3 of Wall Street’s Favorite Stocks We’re Skeptical Of

February 15, 2026

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

Cencora, Azenta, The Pennant Group, LifeStance Health Group, and Gilead Sciences Shares Are Soaring, What You Need To Know

February 13, 2026

A number of stocks jumped in the afternoon session after a softer-than-expected inflation report fueled hopes for interest rate cuts by the Federal Reserve. The January Consumer Price Index (CPI), a...

Via StockStory

Topics Economy

The Top 5 Analyst Questions From Azenta’s Q4 Earnings Call

February 11, 2026

Azenta’s fourth quarter saw a flat sales trajectory, with revenue slightly ahead of Wall Street estimates but non-GAAP profit in line with expectations. The market responded negatively, reflecting...

Via StockStory

Topics Earnings

1 Healthcare Stock with Promising Prospects and 2 Facing Challenges

February 10, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and...

Via StockStory

Topics Stocks

Cold Chain, High Stakes: A Deep Dive into Azenta’s (AZTA) Life Sciences Transformation

February 05, 2026

Date: February 5, 2026 Introduction In the high-stakes world of life sciences, the "cold chain" is the invisible backbone of modern medicine. From the development of mRNA vaccines to the emerging...

Via Finterra

Topics Artificial Intelligence Earnings Economy

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.